| Vertebral artery variations revised: origin, course, branches and embryonic development EP Magklara, ET Pantelia, E Solia, E Panagouli, M Piagkou, A Mazarakis, ... Folia morphologica 80 (1), 1-12, 2021 | 74 | 2021 |
| Three-dimensional (3D) printing in orthopedics education E Maglara, S Angelis, E Solia, AP Apostolopoulos, G Tsakotos, K Vlasis, ... Journal of Long-Term Effects of Medical Implants 30 (4), 2020 | 22 | 2020 |
| The role of medical students during COVID-19 era. A review E Magklara, S Angelis, E Solia, A Katsimantas, G Kourlaba, G Kostakis, ... Acta Bio Medica: Atenei Parmensis 92 (1), e2021032, 2021 | 20 | 2021 |
| Real world efficacy and toxicity of selinexor: importance of patient characteristics, dose intensity and post progression outcomes E Kastritis, M Gavriatopoulou, E Solia, F Theodorakakou, V Spiliopoulou, ... Clinical Lymphoma Myeloma and Leukemia 23 (11), 844-849, 2023 | 4 | 2023 |
| Anatomical Variations of Vascular Anatomy in Meckel’s Diverticulum DM Ntalianis, RN Maloula, KM Ntalianis, P Giavopoulos, E Solia, ... Acta Medica Academica 51 (3), 243, 2022 | 3 | 2022 |
| The Role of Surgical Masks during the COVID-19 Pandemic. A Mini-Review E Solia, S Angelis, E Maglara, G Tsakotos, DK Filippou Journal of long-term effects of medical implants 30 (4), 2020 | 3 | 2020 |
| Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia E Solia, MA Dimopoulos, E Kastritis Hematology/Oncology Clinics 37 (4), 689-705, 2023 | 2 | 2023 |
| Real world efficacy and toxicity of selinexor: importance of dose intensity and post progression outcomes E Kastritis, P Malandrakis, V Spiliopoulou, I Ntanasis-Stathopoulos, ... Blood 140 (Supplement 1), 7152-7153, 2022 | 2 | 2022 |
| Management and outcomes of anti-CD38 refractory myeloma patients: the impact of retreatment and of subsequent therapies E Kastritis, F Theodorakakou, I Ntanasis-Stathopoulos, V Spiliopoulou, ... Blood 140 (Supplement 1), 7324-7325, 2022 | 2 | 2022 |
| Variations of ulnar nerve in the forearm and hand: A review of the literature and clinical significance E Solia, S Angelis, AP Apostolopoulos, DK Filippou Journal of Long-Term Effects of Medical Implants 32 (1), 2022 | 2 | 2022 |
| Management and outcomes of anti-CD38 refractory patients: the impact of retreatment and of subsequent therapies E Kastritis, F Theodorakakou, I Ntanasis-Stathopoulos, V Spiliopoulou, ... HemaSphere 7 (11), e975, 2023 | 1 | 2023 |
| Anatomical variations in the celiac trunk: a short review I Vougadiotis, V Karampelias, D Chrysikos, IAE Solia, Y Spanidis, ... Acta Medica Academica 52 (2), 134, 2023 | 1 | 2023 |
| Duplicated inferior vena cava-trifurcated portal vein: a rare anatomical variation encountered during Whipple procedure D Chrysikos, S Delis, D Smerdi, E Charitaki, E Solia, T Troupis Journal of Surgical Case Reports 2023 (1), rjad014, 2023 | 1 | 2023 |
| The Coronoid Anatomical Variation of the Masseter Muscle: A Case Report D Chrysikos, E Solia, K Karamouzis, G Tsakotos, A Samolis, ... Journal of Long-Term Effects of Medical Implants 33 (4), 2023 | 1 | 2023 |
| Synthetic vs. biologic mesh for abdominal wall reconstruction in contaminated surgical fields. A meta-analysis of randomized controlled trials and observational studies M Frountzas, D Kanata, E Solia, D Smerdi, C Nikolaou, A Chamzin, ... Hernia 29 (1), 1-13, 2025 | | 2025 |
| Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies F Theodorakakou, D Fotiou, V Spiliopoulou, M Migkou, P Malandrakis, ... Amyloid, 1-3, 2025 | | 2025 |
| Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach? E Solia, E Kastritis Therapeutic Advances in Hematology 15, 20406207241308771, 2024 | | 2024 |
| Risk and Patterns of Progression Among Smoldering Myeloma Patients after the Implementation of New Criteria and Modern Imaging E Kastritis, P Malandrakis, I Solia, I Ntanasis-Stathopoulos, ... Blood 144, 4675, 2024 | | 2024 |
| Circulating Tumor Cells By Next Generation Flow Cytometry May be a New Prognostic Biomarkers Among Patients with Asymptomatic Monoclonal Gammopathies P Malandrakis, IV Kostopoulos, I Ntanasis-Stathopoulos, I Solia, ... Blood 144, 1020, 2024 | | 2024 |
| Early Treatment Response Assessment with Sequential Whole Body Magnetic Resonance Imaging in Patients with Newly Diagnosed Multiple Myeloma I Ntanasis-Stathopoulos, M Douka, V Koutoulidis, M Gavriatopoulou, ... Blood 144, 4724, 2024 | | 2024 |
